118 related articles for article (PubMed ID: 2437207)
21. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity.
Lecoeur H; Février M; Garcia S; Rivière Y; Gougeon ML
J Immunol Methods; 2001 Jul; 253(1-2):177-87. PubMed ID: 11384679
[TBL] [Abstract][Full Text] [Related]
22. Natural killer cell cytotoxicity: a methods analysis of 51chromium release versus flow cytometry.
Motzer SA; Tsuji J; Hertig V; Johnston SK; Scanlan J
Biol Res Nurs; 2003 Oct; 5(2):142-52. PubMed ID: 14531218
[TBL] [Abstract][Full Text] [Related]
23. The use of non-radioactive chromium as an alternative to 51Cr in NK assay.
Borella P; Bargellini A; Salvioli S; Medici CI; Cossarizza A
J Immunol Methods; 1995 Oct; 186(1):101-10. PubMed ID: 7561139
[TBL] [Abstract][Full Text] [Related]
24. A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity.
Volgmann T; Klein-Struckmeier A; Mohr H
J Immunol Methods; 1989 Apr; 119(1):45-51. PubMed ID: 2785144
[TBL] [Abstract][Full Text] [Related]
25. Measuring cytotoxicity by bioluminescence imaging outperforms the standard chromium-51 release assay.
Karimi MA; Lee E; Bachmann MH; Salicioni AM; Behrens EM; Kambayashi T; Baldwin CL
PLoS One; 2014; 9(2):e89357. PubMed ID: 24586714
[TBL] [Abstract][Full Text] [Related]
26. Cellular cytotoxicity assessed by the 51Cr release assay. Biological interpretation of mathematical parameters.
Bol SJ; Rosdorff HJ; Ronteltap CP; Hennen LA
J Immunol Methods; 1986 Jun; 90(1):15-23. PubMed ID: 3486921
[TBL] [Abstract][Full Text] [Related]
27. Single and dual labelling of cytotoxic target cells. Comparison of three radioactive tracers, [35S]methionine, [75Se]selenomethionine, and chromium-51.
Heymer J; Leibold W
J Immunol Methods; 1993 May; 161(2):217-22. PubMed ID: 8505550
[TBL] [Abstract][Full Text] [Related]
28. [51Cr release assay].
Orita K; Tanaka K
Nihon Rinsho; 1979 Jun; Suppl():1587-8. PubMed ID: 490947
[No Abstract] [Full Text] [Related]
29. Rapid flow cytometric assay for the assessment of natural killer cell activity.
Chang L; Gusewitch GA; Chritton DB; Folz JC; Lebeck LK; Nehlsen-Cannarella SL
J Immunol Methods; 1993 Nov; 166(1):45-54. PubMed ID: 8228287
[TBL] [Abstract][Full Text] [Related]
30. 51Cr release cytotoxicity radioimmunoassay to detect immune cytotoxic reactions to rat Schwann cells in vitro.
Armati-Gulson PJ; Lisak RP; Kuchmy D; Pollard J
Neurosci Lett; 1983 Mar; 35(3):321-6. PubMed ID: 6843908
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity of B16 melanoma sublines to lymphokine-activated killer cells as determined by 51Cr-release and clonogenic assays.
Tzeng JJ; Barth RF
J Immunol Methods; 1990 Apr; 128(2):257-66. PubMed ID: 2324514
[TBL] [Abstract][Full Text] [Related]
32. An impedance-based cytotoxicity assay for real-time and label-free assessment of T-cell-mediated killing of adherent cells.
Peper JK; Schuster H; Löffler MW; Schmid-Horch B; Rammensee HG; Stevanović S
J Immunol Methods; 2014 Mar; 405():192-8. PubMed ID: 24486140
[TBL] [Abstract][Full Text] [Related]
33. 51Cr-labeled human hepatocytes as target cells for cytotoxicity mediated by freshly isolated liver-infiltrating lymphocytes.
Shimizu Y; Hata K; Herberman RB; Whiteside TL
J Immunol Methods; 1993 Aug; 164(1):69-77. PubMed ID: 8360510
[TBL] [Abstract][Full Text] [Related]
34. A micro-version of the 51Cr release assay for cytotoxic lymphocytes.
Schnagl HY; Boyle W
J Immunol Methods; 1978; 24(1-2):79-88. PubMed ID: 722093
[TBL] [Abstract][Full Text] [Related]
35. Application of the direct beta counter Matrix 96 for cytotoxic assays: simultaneous processing and reading of 96 wells using a 51Cr-retention assay.
Hillman GG; Roessler N; Fulbright RS; Pontes JE; Haas GP
Cancer Immunol Immunother; 1993 Jun; 36(6):351-6. PubMed ID: 8500108
[TBL] [Abstract][Full Text] [Related]
36. Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts.
Dannemann BR; Morris VA; Araujo FG; Remington JS
J Immunol; 1989 Oct; 143(8):2684-91. PubMed ID: 2477453
[TBL] [Abstract][Full Text] [Related]
37. Chromium and tritiated thymidine releases from target cells are differential events in human monocyte/macrophage-mediated cytotoxicity.
Higashi N; Taki H; Nishimura Y; Higuchi M; Osawa T
Cell Immunol; 1993 Sep; 150(2):333-42. PubMed ID: 8370076
[TBL] [Abstract][Full Text] [Related]
38. [Use of peritoneal macrophages labeled with Cr51 and cultivated in vitro as target cells for quantitative assessment of the cytotoxic activity of immune T-lymphocytes].
Drizlikh GI; Andreev AV; Kotomina IF; Brondz DB
Biull Eksp Biol Med; 1976 Mar; 81(3):340-2. PubMed ID: 1085177
[TBL] [Abstract][Full Text] [Related]
39. Real-time viability assay based on 51Cr retention in adherent cells.
Vennström L; Bysell C; Björkelund H; Lundqvist H; Andersson K
Biotechniques; 2008 Feb; 44(2):237-40. PubMed ID: 18330352
[TBL] [Abstract][Full Text] [Related]
40. Ethanol-induced cell damage in cultured rat antral mucosa assessed by chromium-51 release.
Sewell RB; Ling TS; Yeomans ND
Dig Dis Sci; 1986 Aug; 31(8):853-8. PubMed ID: 3731977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
